NICE was unable to develop medical technologies guidance on the Assurance Nasal Alar SpO2 Sensor because no evidence submission was received from the company.
| Status | Discontinued |
| Decision | Selected |
| Process | MTG |
| ID number | 310 |
Email enquiries
- If you have any queries please email medtech@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 27 March 2017 | Discontinued. NICE was unable to develop medical technologies guidance on the Assurance Nasal Alar SpO2 Sensor because no evidence submission was received from the company. |
For further information on our processes and methods, please see our CHTE processes and methods manual